Wall Street Analysts See a 319.23% Upside in Janux Therapeutics (JANX): Can the Stock Really Move This High?

分组1 - Janux Therapeutics, Inc. (JANX) shares have increased by 1.8% over the past four weeks, closing at $13.99, with a mean price target of $58.65 indicating a potential upside of 319.2% [1] - The mean estimate consists of 17 short-term price targets with a standard deviation of $34.53, where the lowest estimate is $12.00 (14.2% decline) and the highest is $150.00 (972.2% increase) [2] - Analysts show strong agreement on the company's ability to report better earnings, with a positive trend in earnings estimate revisions correlating with potential stock price increases [4][11] 分组2 - The Zacks Consensus Estimate for the current year has risen by 0.2% over the past month, with one estimate increasing and no negative revisions [12] - JANX holds a Zacks Rank 2 (Buy), placing it in the top 20% of over 4,000 ranked stocks based on earnings estimates [13] - While the consensus price target may not be a reliable indicator of potential gains, it does provide a directional guide for price movement [14]